Holen Sie sich die Stockscreener-App
68.61
0.05%
-0.2444
Schlusskurs vom Vortag:
$68.85
Offen:
$68.32
24-Stunden-Volumen:
127.16K
Relative Volume:
0.20
Marktkapitalisierung:
$2.62B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-212.18M
KGV:
-11.45
EPS:
-5.9897
Netto-Cashflow:
$-181.33M
1W Leistung:
-3.64%
1M Leistung:
+14.52%
6M Leistung:
-23.24%
1J Leistung:
+51.50%
1-Tages-Spanne:
$68.28
$69.82
1-Wochen-Bereich:
$67.11
$71.96
52-Wochen-Spanne:
$40.00
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Firmenname
Disc Medicine Inc
Sektor
Branche
Telefon
(617) 674-9274
Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
68.70 | 2.63B | 0 | -212.18M | -181.33M | -5.9897 |
VRTX
Vertex Pharmaceuticals Inc
|
427.73 | 109.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
744.11 | 79.46B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
784.36 | 48.52B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
305.79 | 40.77B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
299.59 | 33.39B | 5.36B | 287.73M | 924.18M | 2.5229 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Fortgesetzt | Stifel | Buy |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-11 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-17 | Eingeleitet | Raymond James | Outperform |
| 2023-04-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Eingeleitet | Stifel | Buy |
| 2023-04-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-03-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Disc Medicine and Sanofi reportedly face delays for FDA national priority review vouchers - MSN
Disc Medicine prices upsized securities offering to raise total $250M - MSN
Disc Medicine plunges on FDA complete response letter for bitopertin - MSN
Will Insider 10b5-1 Sales and New ASCO Data Shift Disc Medicine's (IRON) Narrative? - Sahm
ROSEN, HIGHLY RANKED INVESTOR RIGHTS COUNSEL, Encourages ODDITY Tech Ltd. Investors With Losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action– ODD - GlobeNewswire Inc.
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - Scott Coop
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - PR Newswire
IRON Price Today: Disc Medicine, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Disc Medicine (NASDAQ:IRON) Upgraded at Wall Street Zen - MarketBeat
IRON Stock Price, Quote & Chart | DISC MEDICINE INC (NASDAQ:IRON) - ChartMill
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Disc Medicine Completes Key Phase 1b Study of DISC-0974 in CKD Anemia: What Investors Should Watch - TipRanks
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are ... - Bluefield Daily Telegraph
IRON Investor News: If You Have Suffered Losses in Disc - GlobeNewswire
Disc Medicine to present myelofibrosis trial data at ASCO meeting By Investing.com - Investing.com India
Discipline and Rules-Based Execution in IRON Response - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.IRON - FinancialContent
Disc Medicine Insider Sells $380K in Stock Amid 70% One-Year Surge - Yahoo Finance
Disc Medicine to present myelofibrosis trial data at ASCO meeting - Investing.com
Disc Medicine, Inc. to Present RALLY-MF Trial Data on DISC-0974 at ASCO Annual Meeting 2026 - Quiver Quantitative
Disc Medicine announced that the Phase 2 clinical trial data of its drug DISC-0974 in patients with myelofibrosis-associated anemia (RALLY-MF) have been selected for an oral presentation at the annual meeting of the American Society of Clinical Oncology. - Bitget
Myelofibrosis anemia data lands ASCO oral presentation on June 2 - Stock Titan
Short Interest in Disc Medicine, Inc. (NASDAQ:IRON) Rises By 21.4% - MarketBeat
IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates - GlobeNewswire
Insider Sell: Jean Franchi Sells Shares of Disc Medicine Inc (IR - GuruFocus
William Jacob Savage Sells 5,731 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Jean Franchi Sells 6,257 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine Insider Sold Shares Worth $380,449, According to a Recent SEC Filing - marketscreener.com
Disc Medicine CFO Franchi sells $460k in stock By Investing.com - Investing.com Canada
William Savage, chief medical officer, sells Disc Medicine shares for $380k - Investing.com Canada
Disc Medicine (NASDAQ: IRON) CMO sells 5,731 shares under 10b5-1 plan - Stock Titan
Disc Medicine (IRON) CFO sells 6,657 shares under 10b5-1 plan - Stock Titan
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inqui - GuruFocus
Press releases provided by CNW - Techaeris
IRON (NASDAQ: IRON) affiliate files Form 144, reports planned sale of 5,731 shares - Stock Titan
Panic Selling: Whats Disc Medicine Incs historical returnQuarterly Earnings Summary & Real-Time Buy Signal Notifications - baoquankhu1.vn
Volume Recap: Can Disc Medicine Inc outperform in the next rally2026 Sector Review & Breakout Confirmation Alerts - baoquankhu1.vn
Pullback Watch: Whats the beta of Disc Medicine Inc stock2026 Market Sentiment & Weekly Return Optimization Plans - baoquankhu1.vn
Behavioral Patterns of IRON and Institutional Flows - Stock Traders Daily
Gainers Report: Whats Disc Medicine Incs historical return2026 AllTime Highs & Capital Protection Trade Alerts - baoquankhu1.vn
Will Disc Medicine (IRON) Stock Grow in 2026 | Price at $66.45, Up 0.27%Trending Social Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Disc Medicine Hits 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, ... - Bluefield Daily Telegraph
Volatility Watch: Is Disc Medicine Inc stock good for income investors2026 Geopolitical Influence & Safe Entry Zone Identification - baoquankhu1.vn
Aberdeen Group plc Purchases 202,297 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (IRON) Is Up 7.2% After Advancing Bitopertin Phase 3 Despite FDA Efficacy Concerns - simplywall.st
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
Disc Medicine Inc-Aktie (IRON) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Franchi Jean M. | Chief Financial Officer |
Apr 14 '26 |
Sale |
69.24 |
6,257 |
433,234 |
64,333 |
| Franchi Jean M. | Chief Financial Officer |
Apr 13 '26 |
Sale |
69.00 |
400 |
27,600 |
70,590 |
1.73%
2.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):